ES2743604T3 - Producto y procedimiento para el tratamiento de la diarrea - Google Patents

Producto y procedimiento para el tratamiento de la diarrea Download PDF

Info

Publication number
ES2743604T3
ES2743604T3 ES17189072T ES17189072T ES2743604T3 ES 2743604 T3 ES2743604 T3 ES 2743604T3 ES 17189072 T ES17189072 T ES 17189072T ES 17189072 T ES17189072 T ES 17189072T ES 2743604 T3 ES2743604 T3 ES 2743604T3
Authority
ES
Spain
Prior art keywords
receptor antagonist
diarrhea
treatment
patient
cetirizine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17189072T
Other languages
English (en)
Spanish (es)
Inventor
Ii Reed B Hogan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAREGADE RX LLC
Original Assignee
MAREGADE RX LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAREGADE RX LLC filed Critical MAREGADE RX LLC
Application granted granted Critical
Publication of ES2743604T3 publication Critical patent/ES2743604T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES17189072T 2013-03-14 2014-03-14 Producto y procedimiento para el tratamiento de la diarrea Active ES2743604T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361782608P 2013-03-14 2013-03-14

Publications (1)

Publication Number Publication Date
ES2743604T3 true ES2743604T3 (es) 2020-02-20

Family

ID=50680150

Family Applications (2)

Application Number Title Priority Date Filing Date
ES14722445.5T Active ES2655505T3 (es) 2013-03-14 2014-03-14 Producto y procedimiento para el tratamiento de la diarrea
ES17189072T Active ES2743604T3 (es) 2013-03-14 2014-03-14 Producto y procedimiento para el tratamiento de la diarrea

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES14722445.5T Active ES2655505T3 (es) 2013-03-14 2014-03-14 Producto y procedimiento para el tratamiento de la diarrea

Country Status (20)

Country Link
US (4) US9717726B2 (enExample)
EP (3) EP2968205B1 (enExample)
JP (4) JP6313417B2 (enExample)
KR (4) KR20180088514A (enExample)
CN (2) CN108939076A (enExample)
AU (3) AU2014239878B2 (enExample)
BR (2) BR112015022513A2 (enExample)
CA (1) CA2906005C (enExample)
DK (1) DK2968205T3 (enExample)
ES (2) ES2655505T3 (enExample)
HK (1) HK1247557B (enExample)
HU (1) HUE035201T2 (enExample)
IL (3) IL273377B2 (enExample)
MX (2) MX366329B (enExample)
MY (1) MY175326A (enExample)
PL (1) PL2968205T3 (enExample)
PT (1) PT2968205T (enExample)
RU (1) RU2015143475A (enExample)
WO (1) WO2014152420A2 (enExample)
ZA (1) ZA201708539B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9717726B2 (en) 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
WO2015073573A1 (en) * 2013-11-14 2015-05-21 Jacobs Michael M Compositions and methods for the prevention and treatment of alcohol-induced hangover syndrome
ES2953520T3 (es) 2016-12-23 2023-11-14 Maregade Rx Llc Producto a baja dosis y método para el tratamiento de la diarrea
IT201900012645A1 (it) * 2019-07-23 2021-01-23 Eros Zanotti Una composizione farmaceutica per l'uso nel trattamento delle chinetosi
CN112616320B (zh) * 2019-08-05 2024-04-05 株式会社日立高新技术 等离子处理装置
US20220408780A1 (en) * 2020-02-11 2022-12-29 The E. Wolfson Medical Center A method effective for treating ulcerative colitis
CA3233054A1 (en) * 2021-09-22 2023-03-30 Hista Rx Llc Compositions and methods for treating and preventing interstitial cystitis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
US5096894A (en) * 1990-04-03 1992-03-17 Bristol-Myers Squibb Company Rice dextrin oral rehydration solution
AU7255094A (en) 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-antihistamine combinations
US6264984B1 (en) * 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
US6656492B2 (en) * 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
BR0116178A (pt) 2000-11-30 2003-10-14 Bio Balance Corp Cepa bacterial, composição probiótica compreendendo uma cepa bacterial, formulação compreendendo pelo menos uma fração volátil de um extrato de planta, aditivo alimentar, processo de preparação de uma fração volátil de uma planta, processo de preparação de uma formulação terapêutica, processo de crescimento de uma cepa bacterial, processo de manufatura de uma composição probiótica, processo de preparo de uma composição probiótica, processo de preparo de uma composição incluindo microorganismos viáveis, dispensador de microorganismo, método de bio controle de um organismo, método para eliminar uma poluição de óleo, método de recuperação de fumaças org‰nicas, produto alimentar e método de preparo inicial para um processo de fermantação
PT1451196E (pt) * 2001-11-23 2007-10-25 Janssen Pharmaceutica Nv Utilização de anti-histamínicos para redução aguda de pressão intracraniana elevada
SE528789C2 (sv) 2004-09-10 2007-02-13 Sandvik Intellectual Property PVD-belagt skär av hårdmetall samt sätt att tillverka detta
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
WO2007111945A2 (en) 2006-03-22 2007-10-04 Trustees Of Boston University Method for management of diarrhea
US8207188B2 (en) 2006-04-07 2012-06-26 Michalis Nicolaou Treatment of diseases modulated by a H4 receptor agonist
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20090042972A1 (en) * 2006-05-19 2009-02-12 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
EP2170317A4 (en) 2007-02-12 2011-03-23 Mike Nicolaou TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), GASTRO-OESOPHAGEAL REFLUX DISEASE (GERD), FOOD ALLERGIES, AND OTHER DISEASES AND GASTROINTESTIN DISORDERS AFFECTED BY APPROPRIATE MANAGEMENT OF HISTAMINE USING A COMBINATION OF INHIBITORS HISTIDINE DECARBOXYLASE, MEDICAMEN
WO2008128115A2 (en) * 2007-04-13 2008-10-23 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
CN105051192B (zh) 2012-11-13 2020-04-17 科迪艾克生物科学公司 治疗剂的递送
US9717726B2 (en) * 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
ES2953520T3 (es) 2016-12-23 2023-11-14 Maregade Rx Llc Producto a baja dosis y método para el tratamiento de la diarrea

Also Published As

Publication number Publication date
MX350814B (es) 2017-09-21
KR102449977B1 (ko) 2022-09-30
ZA201708539B (en) 2019-05-29
JP2018135340A (ja) 2018-08-30
CA2906005A1 (en) 2014-09-25
JP2021046400A (ja) 2021-03-25
JP6313417B2 (ja) 2018-04-18
WO2014152420A2 (en) 2014-09-25
US10034875B2 (en) 2018-07-31
EP2968205A2 (en) 2016-01-20
CN108939076A (zh) 2018-12-07
AU2017251701A1 (en) 2017-11-09
US20140275116A1 (en) 2014-09-18
JP6790140B2 (ja) 2020-11-25
MX366329B (es) 2019-07-05
US20170049770A1 (en) 2017-02-23
HK1247557B (en) 2020-07-03
ES2655505T3 (es) 2018-02-20
PL2968205T3 (pl) 2018-03-30
CN105324112B (zh) 2018-08-17
KR20200100211A (ko) 2020-08-25
IL273377A (en) 2020-05-31
JP2016513692A (ja) 2016-05-16
IL273377B1 (en) 2023-06-01
JP6473254B2 (ja) 2019-02-20
IL241372B (en) 2018-06-28
KR20180088514A (ko) 2018-08-03
KR20150139535A (ko) 2015-12-11
US20190038619A1 (en) 2019-02-07
IL273377B2 (en) 2023-10-01
WO2014152420A3 (en) 2014-11-20
HK1213205A1 (en) 2016-06-30
PT2968205T (pt) 2018-01-05
AU2017251701B2 (en) 2019-03-14
IL256300B (en) 2020-04-30
RU2015143475A (ru) 2017-04-20
EP3269364A1 (en) 2018-01-17
KR20210021606A (ko) 2021-02-26
US11058681B2 (en) 2021-07-13
EP3581205A2 (en) 2019-12-18
BR122017004716A2 (pt) 2019-07-30
EP3581205A3 (en) 2020-03-25
AU2014239878B2 (en) 2017-08-24
US20220047583A1 (en) 2022-02-17
MY175326A (en) 2020-06-19
IL256300A (en) 2018-02-28
AU2019201412A1 (en) 2019-03-21
MX2015011885A (es) 2016-05-16
BR112015022513A2 (pt) 2017-07-18
EP2968205B1 (en) 2017-10-11
CA2906005C (en) 2021-12-28
JP2019089796A (ja) 2019-06-13
HUE035201T2 (hu) 2018-05-02
DK2968205T3 (da) 2017-11-27
IL241372A0 (en) 2015-11-30
AU2014239878A1 (en) 2015-10-15
KR101884506B1 (ko) 2018-08-01
CN105324112A (zh) 2016-02-10
US9717726B2 (en) 2017-08-01
EP3269364B1 (en) 2019-05-29

Similar Documents

Publication Publication Date Title
ES2743604T3 (es) Producto y procedimiento para el tratamiento de la diarrea
HK1247557A1 (en) Product and method for treating diarrhea
US20250325540A1 (en) Low dose product and method for treating diarrhea
JP2016513692A5 (enExample)
HK1213205B (en) Product and method for treating diarrhea